<p>Roivant Sciences Ltd. has reported the acquisition of common shares of Immunovant Inc., according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-045409), on December 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

IMVT

ROIV

<p>Roivant Sciences Ltd. has acquired common shares of Immunovant Inc., as reported in a recent SEC filing. This acquisition was disclosed by Immunovant Inc. through the EDGAR system on December 12, 2025. The information is provided by Public Technologies (PUBT) and is for informational purposes only.</p>

Roivant Sciences Ltd. Reports Acquisition of Immunovant Inc. Common Shares